Search Results 571-580 of 15166 for alt

1. Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer - Mayo Clinic

   ... [ALT]) ≤ 3 x ULN or SGOT (AST) and SGPT (ALT) ≤ 5 x ULN if elevations are due to liver metastases. - Alkaline phosphatase ≤ 2.5 x ULN or alkaline ...

2. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   Abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; CrCl = creatinine clearance; GFR = glomerular filtration rate; INR ...

3. Combination Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Young Patients with Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma - Mayo Clinic

   AST and ALT < 2 times ULN; Shortening fraction ≥ 27% by echocardiogram; Ejection fraction ≥ 47% by radionuclide angiogram; No evidence of dyspnea at rest ...

4. Molecular Regulation of Muscle Glucose Metabolism - Mayo Clinic

   ALT (SGPT) < 2 times upper limit of normal; Alkaline phosphatase < 2 times upper limit of normal; Triglycerides < 150 mg/dl. PT 11.7 -14.3 (During Liposyn ...

5. A Study to Evaluate the Impact on NASH with Fibrosis of Obeticholic Acid Treatment - Mayo Clinic

   ALT > 1.5 × upper limit of normal (ULN). For subjects with a historical biopsy, is either not taking or is on stable doses of TZDs/glitazones or vitamin E ...

6. Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD - Mayo Clinic

   Abnormal liver function as indicated by elevated AST or ALT. Any elevation of AST or ALT level >2x upper limit of normal (ULN) will require Sponsor review and ...

7. Alpha-1-antitrypsin deficiency - Symptoms and causes - Mayo Clinic

   Learn about the symptoms and risk factors of alpha-1-antitrypsin deficiency, a condition passed down in families, that can affect the lungs, liver or both.

8. A Study of Lacosamide to Treat Neonatal Seizures - Mayo Clinic

   ... (ALT), and alkaline phosphatase (ALP), with the following exception: For participants with perinatal asphyxia, elevation of AST, ALT, or ALP 2mg/dL.

9. TheraSphere With and Without Durvalumab and Tremelimumab for HCC - Mayo Clinic

   ... ALT should be ≤3xULN and for treated patients, antiviral treatment (per local standard of care) should be stopped for a minimum of 14 days prior to study ...

10. A Study to Evaluate Non-invasive Biomarkers of Metabolic Liver Disease - Mayo Clinic

    Abnormal ALT (> 30 U/L for men, > 19 U/L for women) without other common causes such as HCV, HBV AND meets criteria within 36 months for ATP III criteria ...